Quarterly Financials Mar 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue 216
278
260
293
331
402
300
296
300
303
334
328
342
282
314
293
326
384
318
338
319
407
432
421
545
438
450
516
547
Expenses 192
260
276
318
325
350
294
295
292
277
305
288
296
255
300
284
313
302
311
352
345
419
395
407
435
532
403
452
448
EBITDA 24
18
-16
-25
5
52
6
1
8
26
29
40
46
27
14
9
13
83
7
-14
-26
-12
37
14
110
-94
47
64
99
Operating Profit % -3 %
-10 %
-14 %
-22 %
-7 %
7 %
-7 %
-10 %
-6 %
5 %
4 %
9 %
9 %
7 %
-1 %
2 %
-0 %
19 %
-0 %
-7 %
-14 %
-4 %
7 %
2 %
7 %
-23 %
10 %
11 %
16 %
Depreciation 11
14
14
16
18
19
18
21
20
23
21
21
21
22
22
22
23
23
25
28
31
30
29
30
32
27
28
32
31
Interest 0
3
1
1
1
4
1
2
2
2
1
1
1
2
1
2
1
2
3
5
4
6
6
7
6
5
4
5
7
Profit Before Tax 13
2
-31
-43
-14
29
-14
-22
-13
0
7
18
24
3
-9
-16
-11
58
-21
-47
-61
-47
2
-22
73
-126
15
27
62
Tax -16
4
-10
-2
-14
-9
-8
1
1
18
5
9
-0
3
2
-3
3
-14
3
23
3
-3
3
3
0
3
6
3
4
Net Profit 29
-2
-21
-41
-0
38
-6
-22
-15
-17
2
9
24
-0
-12
-13
-14
72
-23
-71
-64
-44
-1
-25
73
-129
9
25
58
EPS in ₹ 3.19
0.00
-2.91
-5.83
-0.04
4.51
-0.88
-3.15
-2.07
-2.44
0.35
1.24
3.35
-0.06
-1.63
-1.82
-2.01
10.15
-3.32
-10.04
-9.08
-6.28
-0.09
-3.48
10.39
-18.37
1.31
3.50
8.22
Above figures are in Rs. Crores Balance Sheet 2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets 1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,169
Fixed Assets 416
403
491
578
810
870
884
990
1,257
1,196
Current Assets 564
600
749
2,337
2,038
1,687
1,377
1,648
1,589
1,694
Capital Work in Progress 123
237
250
238
92
331
568
494
148
123
Investments 35
14
14
901
926
550
392
264
2
1
Other Assets 595
630
772
1,476
1,321
1,395
1,282
1,571
1,787
1,849
Total Liabilities 1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,169
Current Liabilities 212
243
393
464
503
567
506
552
640
708
Non Current Liabilities 89
86
70
50
27
47
63
148
118
99
Total Equity 868
954
1,064
2,680
2,620
2,531
2,557
2,618
2,435
2,362
Reserve & Surplus 849
936
1,045
2,666
2,606
2,517
2,543
2,604
2,421
2,348
Share Capital 18
18
18
14
14
14
14
14
14
14
Above figures are in Rs. Crores Cash Flow 2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow -25
-7
-1
655
-616
-78
-154
32
75
-33
Investing Activities -52
-85
-128
1,648
-286
-36
-66
100
241
57
Operating Activities 78
112
68
-112
-328
20
33
-260
-85
17
Financing Activities -51
-33
59
-881
-2
-62
-121
191
-81
-106
Above figures are in Rs. Crores % Holding Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter 50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
70.21 %
70.22 %
70.22 %
70.22 %
70.22 %
70.22 %
FIIs 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.83 %
0.00 %
0.90 %
0.89 %
0.94 %
1.06 %
DIIs 8.49 %
8.49 %
8.49 %
8.49 %
8.49 %
8.38 %
7.55 %
8.20 %
8.16 %
7.39 %
10.32 %
9.29 %
11.27 %
11.58 %
11.67 %
11.63 %
Government 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail 30.48 %
30.39 %
30.50 %
30.27 %
29.81 %
29.95 %
30.17 %
30.99 %
30.91 %
26.86 %
15.80 %
15.63 %
15.12 %
14.80 %
14.58 %
14.47 %
Others 10.09 %
10.19 %
10.08 %
10.31 %
10.77 %
10.73 %
11.34 %
9.87 %
9.99 %
14.81 %
2.84 %
4.85 %
2.49 %
2.50 %
2.60 %
2.62 %
No of Share Holders 0
33,734
34,258
33,892
35,313
33,557
32,666
29,573
29,418
26,642
21,584
20,877
21,171
20,621
20,374
21,472
Dividend Per Share (₹) 0.00 3 5 4 4 4 4 4 0.00 0.00 Dividend Yield (%) 0.00 1.05 2.57 2.57 1.29 1.54 1.39 0.81 0.00 0.00
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead, Login Open Account
Board Meeting Outcome for Outcome Of Board Meeting 5 days ago Closure of Trading Window 8 days ago Announcement Under Regulation 30 Mar 20, 2025 USFDA Approval For CompanyS Pithampur API Facility Mar 01, 2025 Board Meeting Outcome for Outcome Of Board Meeting Mar 01, 2025 Announcement under Regulation 30 (LODR)-Credit Rating Feb 18, 2025 Announcement under Regulation 30 (LODR)-Newspaper Publication Feb 07, 2025 Integrated Filing (Financial) Feb 06, 2025 Financial Results Feb 06, 2025 Included Mr. Utkarsh Patil Chief Manufacturing Officer - Formulations As A Senior Management Personnel Under SEBI LODR Regulations With Effect From 6Th February 2025 Feb 06, 2025 Board Meeting Outcome for Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine-Months Ended 31St December 2024 Feb 06, 2025 Announcement Under Regulation 30(LODR) - GST (Goods
&Services Tax) Jan 27, 2025 Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Jan 24, 2025 Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024. Jan 14, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Jan 07, 2025 Intimation By Registrar & Transfer Agent (RTA) Jan 03, 2025 Resignation Of Senior Managerial Personnel. Dec 17, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Nov 14, 2024 Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information Nov 13, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Nov 13, 2024 Board Meeting Outcome for Unaudited Financial Statements (Consolidated & Standalone) For The Second Quarter And Half Year Ended 30Th September 2024 Nov 13, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Nov 10, 2024 Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2024. Oct 25, 2024 Reply Letter On A Significant Increase In The Volume. Oct 23, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Oct 11, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Oct 04, 2024 Board Meeting Outcome for Outcome Of Board Meeting Sep 30, 2024 Closure of Trading Window Sep 23, 2024 Board Meeting Intimation for Integration And Consolidation Of The Generics FormulationsBusiness In The US Market. Sep 23, 2024 Intimation Under Regulation 30 Of SEBI LODR Sep 10, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Sep 03, 2024 Announcement under Regulation 30 (LODR)-Change in Registered Office Address Sep 03, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Aug 23, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Aug 09, 2024 Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Aug 08, 2024 Shareholder Meeting / Postal Ballot-Outcome of AGM Aug 08, 2024 Change In Key Managerial Personnel For Determining And Disclosure Of Material Events Aug 08, 2024 Board Meeting Outcome for Outcome Of Board Meeting Aug 08, 2024 Outcome Of Board Meeting Aug 08, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Aug 05, 2024 Board Meeting Intimation for Financial Results Jul 26, 2024 USFDA Inspection At Goa Formulation Facility Jul 15, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Jul 12, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Jul 11, 2024 Notice Of The 61St Annual General Meeting Jul 11, 2024 Business Responsibility and Sustainability Reporting (BRSR) Jul 11, 2024 Reg. 34 (1) Annual Report. Jul 11, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Jul 01, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Jul 01, 2024 Shareholder Meeting - AGM On August 8, 2024 Jun 28, 2024 RSI(14)
Neutral
51.54
ATR(14)
Less Volatile
29.84
STOCH(9,6)
Neutral
66.93
STOCH RSI(14)
Neutral
71.36
MACD(12,26)
Bullish
4.48
ADX(14)
Weak Trend
18.36
UO(9)
Bearish
45.82
ROC(12)
Uptrend And Accelerating
7.38
WillR(14)
Neutral
-38.06